CVS Health (NYSE:CVS), one of the leading health insurers in the U.S. and owner of the Pharmacy Benefit Manager Caremark, ...

Advocates have claimed that CVS’s refusal to cover Yeztugo violates the Affordable Care Act (ACA), which requires insurers to ...

In 2014, Caremark was accused of manipulating how drug costs were reported, prompting Aetna and SilverScript to submit false ...

CVS Health will not cover Gilead's Yeztugo, generic name lenacapavir (LEN), citing "clinical, financial, and regulatory ...

A federal judge has ordered CVS Caremark to pay almost $290 million in damages and penalties after a whistleblower proved the ...

CVS has emerged as an outlier during the ongoing implosion observed in the healthcare insurance sector, as they drive ...

CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to ...

The owner of the U.S.' largest pharmacy benefit manager is declining to cover Gilead Sciences’ long-acting HIV prevention ...

We recently published 12 Latest Stocks On Jim Cramer’s Radar. CVS Health Corporation (NYSE:CVS) is one of the stocks Jim ...

CVS Health Corp., parent of Hartford-based Aetna Inc., said Friday it has agreed to issue and sell $4 billion in notes.

Primary care physicians and the state Senate’s health care point person are questioning a proposed partnership between Mass ...

Through the power of strategic, well-built partnerships, CVS Health helps employees earn degrees — and at no cost to them.